FAM149B1
The Family with sequence similarity 149 member B1 is an uncharacterized protein encoded by the human FAM149B1 gene, with one alias KIAA0974. The protein resides in the nucleus of the cell. The predicted secondary structure of the gene contains multiple alpha-helices, with a few beta-sheet structures. The gene is conserved in mammals, birds, reptiles, fish, and some invertebrates. The protein encoded by this gene contains a DUF3719 protein domain, which is conserved across its orthologues. The protein is expressed at slightly below average levels in most human tissue types, with high expression in brain, kidney, and testes  tissues, while showing relatively low expression levels in pancreas tissues. Gene. This gene has a possible 14 exons. It is located on the forward strand of chromosome 10 at 10q22.2 on the positive strand. The total span of the gene, including 5' and 3' UTR, is 3149 base pairs. The gene is flanked on the left by NUDT13 (nudix hydrolase 13) and on the right by DNAJC9-AS1 (DNAJC9 antisense RNA 1). Isoforms. The FAM149B1 protein has a possible 10 isoforms, which are determined through alternative splicing of the gene. Protein. General properties. The primary protein encoded by the FAM149B1  gene is 583 amino acids in length and has a molecular weight of 64 kDal. The protein contains a conserved protein domain, DUF3719 located at the amino acids 115–179. The isoelectric point of the protein before post-translational modifications is 6.3, and this isoelectric point is relatively conserved in the protein's isoforms, especially in those with the most similar composition of exons. This protein is considered serine rich, in that it expresses a higher serine composition relative to the composition of other human proteins. This high serine composition is also seen in the gene's orthologues. Splice variants. The  splice variants of the protein demonstrate some shared qualities of the protein that is translated from the primary transcript. Because each isoform is a different length and contains various combinations of the available exons, there are variances in the isoelectric point and molecular weight. The isoforms closest to the weight and exon composition to the primary transcript generally share these characteristics. The protein isoforms missing the conserved DUF3719 domain are isoforms X5 and X6 because this domain is contained between exons 3–6. Structure. There is a negative charge cluster from amino acids 212 to 239. Negative charge clusters often coordinate  calcium, or magnesium or zinc ions, mannose-binding protein, or aminopeptidase. The protein contains no positive or mixed charge clusters. The secondary structure of the protein is predicted to be a combination of mostly alpha-helices with a few predicted beta-sheet structures. Subcellular localization. The subcellular location of the protein is the nucleus. There is a leucine zipper pattern in the protein beginning at amino acid 347. Post-translational modifications. Acetylation. The third amino acid in the protein sequence, serine, is predicted to be acetylated. Phosphorylation. There are multiple predicted phosphorylation sites on various serine, tyrosine, and threonine amino  acids are predicted for this protein sequence. The conserved DUF3719 domain contains 7 predicted phosphorylation sites. Sumoylation. One predicted sumoylation site was identified in the protein sequence at K267. Expression. Overall in the human body, this gene is expressed at levels slightly below the average human gene expression level. The protein is expressed in most cell types of the human body. Most experimentation shows a higher expression of this protein in kidney, testes, and brain tissues, with very low expression seen in pancreas tissues. The gene is expressed at lower levels than its normal expression in most cancerous tissues. The  gene is also seen to be expressed most highly in fetal and infantile tissues. DNA microarray data. DNA microarray analysis experiments show expression patterns of FAM149B1 compared to multiple other genes in a sample. FAM149B1 is shown to be at a lower expression level than most other genes in a multiple myeloma cell line and was shown to increase to close to average gene expression levels after the beta-catenin was depleted from the sample. FAM149B1 expression was also shown to decrease to lower than average gene expression levels in an ovarian cancer cell line after the use of an  anticancer drug named NSC319726. Transcriptional regulation. The gene has nine different identified promoter regions, which correlate to the various isoforms of the gene. The promoter for the primary transcript of the gene has binding sites for a variety of different transcription factors. Interacting proteins. Current data supports the FAM149B1 protein interactions with 6 different proteins. One protein was determined to be an interacting protein with FAM149B1 through affinity chromatography techniques. The other five proteins that have been predicted to interact with FAM149B1 protein were found through the process of textmining. Homology/Evolution. Paralog. There is one known paralog, FAM149A. It  is located on the human chromosome 4 at 4q35.1. The function of the protein encoded by this gene is not well understood, but it also contains the DUF3719 protein domain. The protein translated by this gene shares a 21.2% identity with the FAM149B1 protein. The protein sequence is 482 amino acids in length. Orthologs. This gene has orthologues across mammals, birds, reptiles, fish, and some invertebrates. There is a high conservation in mammals, moderate conservation in many of the other vertebrate orthologues, and a low conservation in its few invertebrate orthologues. Clinical significance. While the gene is largely not well  understood by scientists, it is shown to be associated with a wide range of various cancerous tumors. The FAM149B1 gene is also included in a region of 11 genes that comprises one of 15 regions containing mutations associated with the African Pygmy phenotype.